Co-ordination of TGF-β and FGF signaling pathways in bone organ cultures

Aditi Mukherjee, Sai Sai Dong, Thomas Clemens, Jesus Alvarez, Rosa Serra

Research output: Contribution to journalArticle

Abstract

Transforming growth factor-β (TGF-β) is known to regulate chondrocyte proliferation and hypertrophic differentiation in embryonic bone cultures by a perichondrium dependent mechanism. To begin to determine which factors in the perichondrium mediate the effects of TGF-β, we studied the effect of Insulin-like Growth Factor-1 (IGF-I) and Fibroblast Growth Factors-2 and -18 (FGF2, FGF18) on metatarsal organ cultures. An increase in chondrocyte proliferation and hypertrophic differentiation was observed after treatment with IGF-I. A similar effect was seen after the perichondrium was stripped from the metatarsals suggesting IGF-I acts directly on the chondrocytes. Treatment with FGF-2 or FGF-18 resulted in a decrease in bone elongation as well as hypertrophic differentiation. Treatment also resulted in a decrease in BrdU incorporation into chondrocytes and an increase in BrdU incorporation in perichondrial cells, similar to what is seen after treatment with TGF-β1. A similar effect was seen with FGF2 after the perichondrium was stripped suggesting that, unlike TGF-β, FGF2 acts directly on chondrocytes to regulate proliferation and hypertrophic differentiation. To test the hypothesis that TGF-β regulates IGF or FGF signaling, activation of the receptors was characterized after treatment with TGF-β. Activation was measured as the level of tyrosine phosphorylation on the receptor. Treatment with TGF-β for 24 h did not alter the level of IGFR-I tyrosine phosphorylation. In contrast, treatment with TGF-β resulted in and increase in tyrosine phosphorylation on FGFR3 without alterations in total FGFR3 levels. TGF-β also stimulated expression of FGF18 mRNA in the cultures and the effects of TGF-β on metatarsal development were blocked or partially blocked by pretreatment with FGF signaling inhibitors. The results suggest a model in which FGF through FGFR3 mediates some of the effects of TGF-β on embryonic bone formation.

Original languageEnglish (US)
Pages (from-to)557-571
Number of pages15
JournalMechanisms of Development
Volume122
Issue number4
DOIs
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Organ Culture Techniques
Transforming Growth Factors
Bone and Bones
Fibroblast Growth Factor 2
Chondrocytes
Metatarsal Bones
Insulin-Like Growth Factor I
Tyrosine
Phosphorylation
Bromodeoxyuridine
Somatomedins
Osteogenesis

Keywords

  • Cartilage
  • Endochondral bone
  • FGF18
  • FGFR3
  • IGF
  • Perichondrium

ASJC Scopus subject areas

  • Developmental Biology
  • Developmental Neuroscience

Cite this

Co-ordination of TGF-β and FGF signaling pathways in bone organ cultures. / Mukherjee, Aditi; Dong, Sai Sai; Clemens, Thomas; Alvarez, Jesus; Serra, Rosa.

In: Mechanisms of Development, Vol. 122, No. 4, 04.2005, p. 557-571.

Research output: Contribution to journalArticle

Mukherjee, Aditi ; Dong, Sai Sai ; Clemens, Thomas ; Alvarez, Jesus ; Serra, Rosa. / Co-ordination of TGF-β and FGF signaling pathways in bone organ cultures. In: Mechanisms of Development. 2005 ; Vol. 122, No. 4. pp. 557-571.
@article{04bcd39468364e7eadf567272f08f42e,
title = "Co-ordination of TGF-β and FGF signaling pathways in bone organ cultures",
abstract = "Transforming growth factor-β (TGF-β) is known to regulate chondrocyte proliferation and hypertrophic differentiation in embryonic bone cultures by a perichondrium dependent mechanism. To begin to determine which factors in the perichondrium mediate the effects of TGF-β, we studied the effect of Insulin-like Growth Factor-1 (IGF-I) and Fibroblast Growth Factors-2 and -18 (FGF2, FGF18) on metatarsal organ cultures. An increase in chondrocyte proliferation and hypertrophic differentiation was observed after treatment with IGF-I. A similar effect was seen after the perichondrium was stripped from the metatarsals suggesting IGF-I acts directly on the chondrocytes. Treatment with FGF-2 or FGF-18 resulted in a decrease in bone elongation as well as hypertrophic differentiation. Treatment also resulted in a decrease in BrdU incorporation into chondrocytes and an increase in BrdU incorporation in perichondrial cells, similar to what is seen after treatment with TGF-β1. A similar effect was seen with FGF2 after the perichondrium was stripped suggesting that, unlike TGF-β, FGF2 acts directly on chondrocytes to regulate proliferation and hypertrophic differentiation. To test the hypothesis that TGF-β regulates IGF or FGF signaling, activation of the receptors was characterized after treatment with TGF-β. Activation was measured as the level of tyrosine phosphorylation on the receptor. Treatment with TGF-β for 24 h did not alter the level of IGFR-I tyrosine phosphorylation. In contrast, treatment with TGF-β resulted in and increase in tyrosine phosphorylation on FGFR3 without alterations in total FGFR3 levels. TGF-β also stimulated expression of FGF18 mRNA in the cultures and the effects of TGF-β on metatarsal development were blocked or partially blocked by pretreatment with FGF signaling inhibitors. The results suggest a model in which FGF through FGFR3 mediates some of the effects of TGF-β on embryonic bone formation.",
keywords = "Cartilage, Endochondral bone, FGF18, FGFR3, IGF, Perichondrium",
author = "Aditi Mukherjee and Dong, {Sai Sai} and Thomas Clemens and Jesus Alvarez and Rosa Serra",
year = "2005",
month = "4",
doi = "10.1016/j.mod.2004.11.006",
language = "English (US)",
volume = "122",
pages = "557--571",
journal = "Mechanisms of Development",
issn = "0925-4773",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Co-ordination of TGF-β and FGF signaling pathways in bone organ cultures

AU - Mukherjee, Aditi

AU - Dong, Sai Sai

AU - Clemens, Thomas

AU - Alvarez, Jesus

AU - Serra, Rosa

PY - 2005/4

Y1 - 2005/4

N2 - Transforming growth factor-β (TGF-β) is known to regulate chondrocyte proliferation and hypertrophic differentiation in embryonic bone cultures by a perichondrium dependent mechanism. To begin to determine which factors in the perichondrium mediate the effects of TGF-β, we studied the effect of Insulin-like Growth Factor-1 (IGF-I) and Fibroblast Growth Factors-2 and -18 (FGF2, FGF18) on metatarsal organ cultures. An increase in chondrocyte proliferation and hypertrophic differentiation was observed after treatment with IGF-I. A similar effect was seen after the perichondrium was stripped from the metatarsals suggesting IGF-I acts directly on the chondrocytes. Treatment with FGF-2 or FGF-18 resulted in a decrease in bone elongation as well as hypertrophic differentiation. Treatment also resulted in a decrease in BrdU incorporation into chondrocytes and an increase in BrdU incorporation in perichondrial cells, similar to what is seen after treatment with TGF-β1. A similar effect was seen with FGF2 after the perichondrium was stripped suggesting that, unlike TGF-β, FGF2 acts directly on chondrocytes to regulate proliferation and hypertrophic differentiation. To test the hypothesis that TGF-β regulates IGF or FGF signaling, activation of the receptors was characterized after treatment with TGF-β. Activation was measured as the level of tyrosine phosphorylation on the receptor. Treatment with TGF-β for 24 h did not alter the level of IGFR-I tyrosine phosphorylation. In contrast, treatment with TGF-β resulted in and increase in tyrosine phosphorylation on FGFR3 without alterations in total FGFR3 levels. TGF-β also stimulated expression of FGF18 mRNA in the cultures and the effects of TGF-β on metatarsal development were blocked or partially blocked by pretreatment with FGF signaling inhibitors. The results suggest a model in which FGF through FGFR3 mediates some of the effects of TGF-β on embryonic bone formation.

AB - Transforming growth factor-β (TGF-β) is known to regulate chondrocyte proliferation and hypertrophic differentiation in embryonic bone cultures by a perichondrium dependent mechanism. To begin to determine which factors in the perichondrium mediate the effects of TGF-β, we studied the effect of Insulin-like Growth Factor-1 (IGF-I) and Fibroblast Growth Factors-2 and -18 (FGF2, FGF18) on metatarsal organ cultures. An increase in chondrocyte proliferation and hypertrophic differentiation was observed after treatment with IGF-I. A similar effect was seen after the perichondrium was stripped from the metatarsals suggesting IGF-I acts directly on the chondrocytes. Treatment with FGF-2 or FGF-18 resulted in a decrease in bone elongation as well as hypertrophic differentiation. Treatment also resulted in a decrease in BrdU incorporation into chondrocytes and an increase in BrdU incorporation in perichondrial cells, similar to what is seen after treatment with TGF-β1. A similar effect was seen with FGF2 after the perichondrium was stripped suggesting that, unlike TGF-β, FGF2 acts directly on chondrocytes to regulate proliferation and hypertrophic differentiation. To test the hypothesis that TGF-β regulates IGF or FGF signaling, activation of the receptors was characterized after treatment with TGF-β. Activation was measured as the level of tyrosine phosphorylation on the receptor. Treatment with TGF-β for 24 h did not alter the level of IGFR-I tyrosine phosphorylation. In contrast, treatment with TGF-β resulted in and increase in tyrosine phosphorylation on FGFR3 without alterations in total FGFR3 levels. TGF-β also stimulated expression of FGF18 mRNA in the cultures and the effects of TGF-β on metatarsal development were blocked or partially blocked by pretreatment with FGF signaling inhibitors. The results suggest a model in which FGF through FGFR3 mediates some of the effects of TGF-β on embryonic bone formation.

KW - Cartilage

KW - Endochondral bone

KW - FGF18

KW - FGFR3

KW - IGF

KW - Perichondrium

UR - http://www.scopus.com/inward/record.url?scp=15944388991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944388991&partnerID=8YFLogxK

U2 - 10.1016/j.mod.2004.11.006

DO - 10.1016/j.mod.2004.11.006

M3 - Article

VL - 122

SP - 557

EP - 571

JO - Mechanisms of Development

JF - Mechanisms of Development

SN - 0925-4773

IS - 4

ER -